Back to search

Article

Favipiravir-resistant influenza A virus shows potential for transmission

2020-09-01

Abstract excerpt

Favipiravir is a nucleoside analogue which has been licensed to treat influenza in the event of a new pandemic. We previously described a favipiravir resistant influenza A virus generated by in vitro passage in presence of drug with two mutations: K229R in PB1, which conferred resistance at a cost to polymerase activity, and P653L in PA, which compensated for the cost of polymerase activity. However, the clinical...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ed0bb6a3-304d-5fb1-9b1d-5557da2fbf3a
DOI
10.1101/2020.09.01.277343
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Favipiravir-resistant influenza A virus shows potential for transmissionDOI 10.1101/2020.09.01.277343
Select a neighboring publication to make it the new centre.